When I first saw that post on Twitter, I thought that it was odd; because it is just a copy-paste from Cellmid's web site, not even a company review or something.
Seriously though, the shareholders should ask what is happening with ELISA and the 'coronavirus study'. There are no updates about those two. Didn't Cellmid sign an agreement with some Chinese company for the ELISA kits or am I remembering it wrong? How much did they pay for it?
An Updated Valuation of CDY, page-16
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
